Clinical Leader - Helping clinical research professionals connect and collaborate

Working hard for success-GettyImages-2201479298

Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation

To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

GUEST COLUMNISTS

Want To Optimize Clinical Project Team Performance? Try This Formal 'Lessons Learned' Process
Learn how a formal "lessons learned" process can help teams work collaboratively with open, honest, and timely communication to reach thoughtful decisions that lead to on-time, on-budget, and inspection-ready trials.
4 Factors Changing The Way CRAs Monitor Trials
The way CRAs monitor is about to change. Regeneron's Patrick Floody discusses these four factors that will influence it.
How Can AI Change Computerized System Validation?
Learn how AI technologies are changing the computer system validation (CSV) landscape and what you need to understand about this transformation.
Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites
Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.
Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?
New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?
What CROs Do Right Isn't Always Obvious To Research Sites
CROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.
How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials
VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.
3 Clinical Research Attorneys Talk 2026 Trends
Three life sciences legal experts share what they see happening in the year ahead — and what should remain firmly in the past.

CLINICAL TRIAL WHITE PAPERS

Modernizing Clinical Trial Oversight: The Path To Clinical Operations Excellence
Examine the current state of RBQM approaches to virtualizing clinical oversight, and the value that adopting these approaches brings to sponsors, CROs, sites, and ultimately patients.

Deriving Reliable Clinical Outcome Scores From Continuous DHT Data
6/10/2025

DHT-derived endpoints, especially percentile-based metrics, hold promise for robust, scalable measurement in clinical trials—provided they're chosen statistically and with adherence in mind.
Triple-Negative Breast Cancer: Global Clinical Trial Landscape
1/30/2025

With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.
Sickle Cell Cure Within Reach, But At A Steep Cost
7/10/2025

Treatment options for sickle cell disease (SCD) and newly available gene therapies represent a potential cure. However, the latter are costly and thus remain out of reach for many SCD patients.
The Future Of Regulatory Operations
6/3/2024

The pathway to enhancing reliability, compliance, and efficiency across lifecycle management will require embracing technology and process improvement if organizations want to achieve their goals.
How Digitized Protocols Are Accelerating Clinical Research
4/15/2025

Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality
5/8/2024

Discover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.
Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic
7/23/2024

How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.
Vaccine Trial Sees >90% eCOA Adherence
5/1/2024

Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.
A Long COVID Study Sponsor Adopts Integrated eCOA And Cognitive Assessment Solution
8/18/2025

eCOA tools used in a long COVID study enabled remote, real-time symptom tracking, cognitive testing, and patient-reported outcomes, ensuring high-quality data while minimizing patient burden.
Digital Biomarkers Show Pathway To Reduced Study Sample Sizes, Shorter Durations
7/8/2024

Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.
Optimized Processes: A Guide To Lyophilization Cycle Development
6/25/2024

Review the essential phases of the lyophilization cycle — freezing, primary drying, and secondary drying — and critical success factors to achieve optimal product quality and stability.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

Building Patient Trust In Research Through Connection Driven-Transparency

The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
Patient Trust In Pharma Is Low; Here's How To Rebuild It

CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
The U.S. Trial Advantage Is Eroding

Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

FOCUS ON PATIENTS

Building Patient Trust In Research Through Connection Driven-Transparency

The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
Patient Trust In Pharma Is Low; Here's How To Rebuild It

CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials

VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.